Scientists map structure of potent antibody against coronavirus. Scientists have shown that a potent antibody from a COVID-19 survivor interferes with a key feature on the surface of the coronavirus's distinctive spikes and induces critical pieces of those spikes to break off in the process. Source 1s.
Early findings indicate Pfizer COVID-19 vaccine may be 90 percent effective. In a major boost to coronavirus vaccine development, Pfizer announced the preliminarily findings Monday based on 94 infections. Ref. USAToday.
A few hours of flu-like symptoms? ‘Absolutely’ worth it for this woman who was in a COVID-19 vaccine trial. Four hours of body aches cured by a common pain reliever. That’s the extent of the side effects Susan Froehlich endured after taking two shots of an experimental Moderna COVID-19 vaccine. And she would “absolutely” do it again if needed. “I woke up with a horrible stomach ache and headache, and it was like I.. Source 8m.
First person in world, a 90-year-old grandmother in Britain, receives Pfizer's COVID-19 vaccine. The United Kingdom on Tuesday became the first western country to start vaccinating its population against the coronavirus. Around 50 hospitals in the state-run National Health Service started administering the inoculation to people over 80 who are either hospitalized or have outpatient appointments scheduled, along with nursing home workers. The first recipient of the shot was Margaret Keenan, who turns 91 next week. Ref. USAToday.
Concern about loved ones might motivate people to mask up and get vaccine. In a recent survey, people who said social distancing and COVID-safety guidelines violated their personal freedoms responded more positively to these ideas when they felt a loved one might be at risk of severe illness for COVID-19. Source 9r.
Allergists offer reassurance regarding potential allergic reactions to COVID-19 vaccines. Reports of possible allergic reactions to COVID-19 vaccines have raised public concern; however, allergists note that allergic reactions to vaccines are rare, and COVID-19 vaccine allergic reactions will have a similarly low rate of occurrence. Source 2b.